Stock Ratings / Health Care / PLRZ / options

NSPR (38) PMI (61) RVP (33) MODD (36) ⌘ Pro Terminal →

Polyrizon Ltd. (PLRZ) Options Positioning, Max Pain & Unusual Sweeps

$9.00 +4.57% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Polyrizon Ltd. (PLRZ) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • SELL / AVOID Cap $21.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-7.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PLRZ)Realized 20D OHLCV Swing Band: ±12.5%

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±12.5%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (PLRZ)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for PLRZ.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PLRZ)

✓Walkthrough of PLRZ's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PLRZ // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -43.40%▼ DESCENDING CHANNEL

2026-10-30O $9.46H $10.86L $9.00C $9.00VOL 45.9K

RES: $13.65SUP: $7.66SMA50: $10.53SMA200: $12.63

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PLRZ Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PLRZ Butterfly Map → + Track PLRZ →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PLRZ today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PLRZ. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PLRZ today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PLRZ)

Health Care Rank #590 of 1016 ⚔️ NSPR vs PLRZ Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PLRZ vs. NSPR, PMI, RVP, MODD)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Polyrizon Ltd. (PLRZ) ranks #590 by composite RQD confidence (42/100, grade D-) and #825 by equity capitalization ($21.9M). Within this direct 5-issuer industry benchmark cohort, PLRZ leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. PMI currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with PLRZ at 42/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PLRZ ACTIVE Polyrizon Ltd.	D-	42/100	—	—	-25.1%	+4.57%	$21.9M	Benchmark Subject
NSPR InspireMD Inc.	D-	38/100	—	29.5%	-35.0%	-3.55%	$21.0M	/nspr-vs-plrz →
PMI Picard Medical Inc.	C-	61/100	—	—	—	+12.17%	$19.9M	/pmi-vs-plrz →
RVP Retractable Technologies Inc.	E	33/100	—	0.1%	-23.3%	-1.15%	$17.3M	/rvp-vs-plrz →
MODD Modular Medical Inc.	D-	36/100	—	—	-35.0%	-9.95%	$16.3M	/modd-vs-plrz →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001893645

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Polyrizon Ltd. (PLRZ) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$3.3M, operating cash flow of -$4.5M, and free cash flow of -$4.5M (-295.4% YoY). On the balance sheet, PLRZ closed FY2025 with $21.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	-$3.3M	-$4.5M	-$4.5M	$21.4M	—
FY2024 (FY)	2024-12-31	$0	-$1.5M	-$1.1M	-$1.1M	$5.5M	—
FY2023 (FY)	2023-12-31	$0	-$600.0K	-$537.0K	-$537.0K	—	—

3. PLRZ Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PLRZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Polyrizon Ltd. (NASDAQ: PLRZ) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $9.00 (+4.57% 1D, market cap $21.9M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, PLRZ ranks #590 in composite RQD confidence.

How does PLRZ compare to NSPR and PMI in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), PLRZ carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -25.1%. By comparison, NSPR (InspireMD Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $21.0M) and PMI (Picard Medical Inc.) posts a C- grade (61/100 RQD, P/E N/A, ROIC —, cap $19.9M). Among the 5-stock peer group, PLRZ leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PLRZ?

Per PLRZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001893645), Polyrizon Ltd. generated $0 in revenue, -$3.3M in net income, and -$4.5M in free cash flow against $21.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PLRZ trading relative to its 50-day, 200-day, and 52-week technical levels?

PLRZ last traded at $9.00 (+4.57% on volume of 8,299 shares), positioning the stock -14.53% below its 50-day simple moving average ($10.53) and -28.74% below its 200-day simple moving average ($12.63). Across its 52-week range of $2.88 to $18.20, PLRZ sits at the 39.9% percentile with a 14-day RSI of 59.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($7.87 to $10.13).